AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need... Show more
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AILCX | 18.13 | 0.09 | +0.50% |
| American Beacon International Eq C | |||
| SRORX | 14.66 | 0.04 | +0.27% |
| Calamos Antetokounmpo Sustainable Eqs R6 | |||
| GSCLX | 31.15 | N/A | N/A |
| Goldman Sachs Large Cap Gr Insghts Svc | |||
| JLCVX | 71.89 | N/A | N/A |
| JHancock Fundamental Large Cap Core R5 | |||
| RTITX | 13.84 | N/A | N/A |
| Russell Inv Multifactor Intl Eq M | |||